Table 2 Clinicopathological features of the patients in cohort 2 (N = 106)
Clinicopathological features | n | LC | P value | LWR | P value | ||
|---|---|---|---|---|---|---|---|
Decreased | Increased | Decreased | Increased | ||||
Age (M (P 25 ~ P 75)) | 106 | 64(56-69) | 62(53-72) | 0.3708 | 64(56-72) | 62(53-70) | 0.2784 |
Gender | 0.0517 | 0.9756 | |||||
Male | 56(52.83%) | 23(43.40%) | 33(62.26%) | 36(52.94%) | 20(52.63%) | ||
Female | 50(47.17%) | 30(56.60%) | 20(37.74%) | 32(47.06%) | 18(47.37%) | ||
Tumor stage | 0.0382 | 0.0010 | |||||
III | 13(12.26%) | 3(5.66%) | 10(18.87%) | 3(4.41%) | 10(26.32%) | ||
IV | 93(87.74%) | 50(94.34%) | 43(81.13%) | 65(95.59%) | 28(73.68%) | ||
Primary tumor site | 0.6794 | 0.3937 | |||||
Gastrointestinal tumors | 60(56.60%) | 33(62.26%) | 27(50.94%) | 41(60.29%) | 19(50.00%) | ||
Thoracic ancer | 14(13.21%) | 6(11.32%) | 8(15.09%) | 9(13.24%) | 5(13.16%) | ||
Urogenital neoplasms | 23(21.70%) | 9(16.98%) | 14(26.42%) | 11(16.18%) | 12(31.58%) | ||
Head and neck neoplasm | 6(5.66%) | 3(5.66%) | 3(5.66%) | 5(7.35%) | 1(2.63%) | ||
Other tumors | 3(2.83%) | 2(3.77%) | 1(1.89%) | 2(2.94%) | 1(2.63%) | ||
Family history | 0.2943 | 0.4234 | |||||
No | 73(68.87%) | 34(64.15%) | 39(73.58%) | 45(66.18%) | 28(73.68%) | ||
Yes | 33(31.13%) | 19(35.85%) | 14(26.42%) | 23(33.82%) | 10(26.32%) | ||
Smoking history | 0.0905 | 0.8157 | |||||
No | 74(69.81%) | 41(77.36%) | 33(62.26%) | 48(70.59%) | 26(68.42%) | ||
Yes | 32(30.19%) | 12(22.64%) | 20(37.74%) | 20(29.41%) | 12(31.58%) | ||
ECOG | 0.1093 | 0.6462 | |||||
< 3 | 81(76.42%) | 37(69.81%) | 44(83.02%) | 51(75.00%) | 30(78.95%) | ||
> =3 | 25(23.58%) | 16(30.19%) | 9(16.98%) | 17(25.00%) | 8(21.05%) | ||
Concomitant disease | 0.5529 | 0.8093 | |||||
No | 63(59.43%) | 33(62.26%) | 30(56.60%) | 41(60.29%) | 22(57.89%) | ||
Yes | 43(40.57%) | 20(37.74%) | 23(43.40%) | 27(39.71%) | 16(42.11%) | ||
Nutrient status | 0.9360 | 0.4560 | |||||
Normal | 42(40.00%) | 21(40.38%) | 21(39.62%) | 25(37.31%) | 17(44.74%) | ||
Abnormal | 63(60.00%) | 31(59.62%) | 32(60.38%) | 42(62.69%) | 21(55.26%) | ||
Unknown | 1 | 1 | - | 1 | - | ||